Moreover, it was recently found that CCR5 is expressed on MDSC in RET transgenic melanoma-bearing mice and melanoma patients, playing an important role in their recruitment to the tumor microenvironment via the CCR5 ligands (CCL3, CCL4, and CCL5) (74, 75). Here, RET is linked to melanoma.